Skip to content
healthcare.dev

DECITABINE

NDC 75834-190, decitabine, injection, powder, lyophilized, for solution, from Nivagen Pharmaceuticals, Inc..

Product NDC
75834-190
Status
Listed
Labeler
Nivagen Pharmaceuticals, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212117
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/75834-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DECITABINE50 mg/20mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
75834-190-01758340190011 VIAL in 1 CARTON (75834-190-01) / 20 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/150537a8-10ac-422d-bf33-68b1a408e566
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=75834-190

Use it

Look up 75834-190 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/75834-190 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 75834-190. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.